Document is current

Any future updates will be listed below

Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy

Crossref DOI link: https://doi.org/10.1186/s13046-015-0282-y

Published Online: 2016-01-06

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark